TScan Therapeutics Inc
NASDAQ:TCRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
TScan Therapeutics Inc
NASDAQ:TCRX
|
US |
|
Apollo Global Management Inc
NYSE:APO
|
US |
|
V
|
Vodacom Group Ltd
JSE:VOD
|
ZA |
|
2
|
2G Energy AG
XETRA:2GB
|
DE |
|
Cambium Networks Corp
NASDAQ:CMBM
|
US |
|
Transcontinental Inc
TSX:TCL.A
|
CA |
|
Aquaporin A/S
CSE:AQP
|
DK |
|
F
|
Fujian Nanwang Environment Protection Scien-tech Co Ltd
SZSE:301355
|
CN |
|
Yara International ASA
OTC:YARIY
|
NO |
|
Alta Equipment Group Inc
NYSE:ALTG
|
US |
|
F
|
Finbond Group Ltd
JSE:FGL
|
ZA |
|
I
|
IN8BIO, Inc.
NASDAQ:INAB
|
US |
|
Nuvista Energy Ltd
TSX:NVA
|
CA |
|
McKay Securities PLC
LSE:MCKS
|
UK |
|
Dais Corp
OTC:DLYT
|
US |
|
Fsn E-Commerce Ventures Ltd
NSE:NYKAA
|
IN |
|
Syndax Pharmaceuticals Inc
NASDAQ:SNDX
|
US |
|
Alligator Bioscience AB
STO:ATORX
|
SE |
|
PJT Partners Inc
NYSE:PJT
|
US |
|
R
|
RFG Holdings Ltd
JSE:RFG
|
ZA |
|
U
|
Unilever PLC
VSE:ULVR
|
UK |
|
Kanani Industries Ltd
NSE:KANANIIND
|
IN |
|
Los Andes Copper Ltd
XTSX:LA
|
CA |
|
R
|
RR Donnelley & Sons Co
F:DLLN
|
US |
Bankruptcy Probability
TScan Therapeutics Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
TScan Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
T
|
TScan Therapeutics Inc
NASDAQ:TCRX
|
58.6m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
380.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
362.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
174.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
68.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
TScan Therapeutics Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, TScan Therapeutics Inc has total debt of 32.5m USD. This includes both short-term (0 USD) and long-term (32.5m USD) debt.
You can find a full breakdown on its Balance Sheet.
